Zibo Hangyu Biotechnology Development

Zibo Hangyu Biotechnology Development is a specialized pharmaceutical company focused on the research, development, and industrial production of peptide drugs and biochemical reagents. Founded in 1997 and based in Zibo, Shandong, the company has built a robust portfolio of immune-modulating therapies, including Thymosin alpha 1 (Thymalfasin) and Thymopentin. Beyond immunology, the firm manufactures peptide hormones such as Alarelin and Somatostatin for oncology and reproductive health applications. Zibo Hangyu operates GMP-certified facilities and serves as a contract manufacturer for pharmaceutical intermediates. The company provides high-purity peptides to both domestic Chinese markets and international research and clinical sectors.